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Human B19 erythrovirus replicates in erythroid progenitors present in bone marrow and fetal tissues where partial oxygen tension is low.
Here we show that infected human primary erythroid progenitor cells exposed to hypoxia (1%O2) in vitro increase viral capsid protein synthesis,
virus replication, and virus production. Hypoxia-inducible factor-1 (HIF-1), the main transcription factor involved in the cellular response to
reduced oxygenation, is shown to bind an HIF binding site (HBS) located in the distal part of the B19 promoter region, but the precise
mechanism involved in the oxygen-sensitive upregulation of viral gene expression remains to be elucidated.
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Introduction tides of unknown functions (Morinet et al., 2000). The virusHuman B19 erythrovirus (B19), the only parvovirus
clearly linked to human disease, is a small non-enveloped
icosahedral virus. Its genome consists of a single-stranded
linear DNA (5596 nucleotides) composed of an internal
coding sequence flanked by inverted terminal repeats of
383 nucleotides each. P6, the only functionally active viral
promoter, is located in the 5V terminal region and regulates
the synthesis of all nine viral transcripts that encode a
multifunctional nonstructural protein (NS1), two structural
capsid proteins (VP1 and VP2), and several small polypep-0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2004.06.020
Abbreviations: B19, human B19 erythrovirus; HIF-1, hypoxia-inducible
factor-1; HBS, HIF-1 DNA-binding site; ARNT, aryl hydrocarbon receptor
nuclear translocator.
* Corresponding author. Laboratoire de Bacte´riologie-Virologie, Hoˆpi-
tal Nord, CHU de Saint-Etienne, 42055 Saint Priest en Jarez, France. Fax:
+33-4-77-82-81-52.
E-mail address: sylvie.pillet@univ-st-etienne.fr (S. Pillet).
1 Present address: Service de Pharmacie, Hopital Trousseau, Paris.
2 Present address: Service d’He´matologie Biologique, Groupe hospi-
talier Pitie´-Salpeˆtrie`re, and Inserm E210, Necker-Enfants Malades, Paris.infects human erythroid progenitor cells in bone marrow and
fetal hematopoietic tissues leading to inhibition of erythroid
colony production. This cytotoxicity results in hypoplastic
anemia in infected humans, sometimes leading to hydrops
foetalis and severe erythroblastopenia in sensitive patients
(Brown and Young, 1997). Given that oxygen concentration
in bone marrow is low (Harrison et al., 2002; Ishikawa and
Ito, 1988) and that fetal development occurs under low
oxygen tension level conditions (Adelman et al., 1999;
Gassmann et al., 1996; Iyer et al., 1998), we wondered if
reduced oxygenation (hypoxia) could influence B19 gene
expression and replication in vitro, thereby contributing to
the viral tropism.
Results
Hypoxia enhances B19 parvovirus protein synthesis
and replication
To analyze whether hypoxia influences B19 erythrovirus
gene expression and replication, CD36+ human primary
Fig. 1. Oxygen-regulated B19 erythrovirus expression in primary erythroid
cells. (A) Northern blot analysis of total RNA extracted from CD36+ cells.
Cells were infected under normoxia, and subsequently cultured under
normoxic or hypoxic conditions for 48 h. Specific viral mRNA is indicated
according to the currently accepted human B19 erythrovirus transcription
map (Morinet et al., 2000). Hypoxia-mediated transcriptional induction of
cellular aldolase, an oxygen-regulated gene (Semenza et al., 1996), served
as a positive control for hypoxic exposure (data not shown). Radioactive
signals were quantified by phosphorimaging. B19 mRNA signals were
normalized to the signal obtained with a 28S cDNA probe, an oxygen-
insensitive quantity control (Zhong and Simons, 1999). Activation factors
were then calculated. Similar data were obtained in three independent
experiments. M: RNA marker (single strand 0.28–6.58 kb ladder,
Promega). (B) Immunoblot analysis of viral VP2 protein using whole-
cell extracts prepared from CD36+ primary erythroid cells infected under
normoxia, and cultured under normoxic or hypoxic conditions during 24 or
48 h. The signal obtained with an anti-actin antibody was used as a control
for loading and transfer efficiency. Similar data were obtained in three
independent experiments. (C) Detection of viral NS1 protein by indirect
immunofluorescence analysis is shown. CD36+ cells were infected under
normoxia and incubated during 24 h in normoxic (N) or hypoxic (H)
conditions as mentioned above. Similar data were obtained in three
independent experiments. (D) Southern blot analysis of viral replicative
forms extracted from CD36+ cells infected under normoxia, and incubated
under normoxic and hypoxic conditions for 48 h. To prove that the B19
DNA present in CD36+ cells (lanes 1 and 3) corresponds to replicative
forms, viral DNA was digested with BamHI restriction enzyme prior
electrophoresis (lanes 2 and 4). The characteristic DNA doublets (1.4/1.5
and 3.8/3.9 kb) are indicated by arrows (Ozawa et al., 1986). Viral DNA
extracted from infectious particles present in a high viremic serum does not
form similar doublets and was simultaneously analyzed, emphasizing the
replicative nature of the B19 DNA detected in lanes 5 and 6. Radioactive
signals were quantified by phosphorimaging. Similar data were obtained in
three independent experiments. M: DNA marker (1 kb ladder, Promega).
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multiplicity of infection of 0.1 and then incubated at nor-
moxic (20% O2) or hypoxic (1% O2) conditions. After 48 h
of exposure, viral mRNA steady-state levels and protein
levels were analyzed. As shown in Fig. 1A, hypoxia led to an
about sevenfold increase of the viral transcripts coding for
VP2, NS1, and small mRNAs, and to a fourfold increase of
the viral transcripts coding for VP1. Immunoblot analysis
revealed that capsid protein VP2, used as a representative
viral protein, strongly accumulated within the CD36+
infected cells after exposure to hypoxia (Fig. 1B), clearly
demonstrating that an oxygen-dependent pathway modulates
viral gene expression. Similarly, hypoxia increased both NS1
protein amounts in B19 erythrovirus-infected cells as well as
the number of NS1-expressing cells (Fig. 1C). As NS1
protein is highly implicated in parvovirus replication by
site-specific DNA nicking within the origin of replication
(Cotmore and Tattersall, 1996), we analyzed if reduced
oxygen tension could also influence viral replication. A
fourfold enhanced production of replicative forms was
detected when CD36+ human primary erythroid cells were
infected and incubated under hypoxic conditions for 48 h
(Fig. 1D). This result was finally consolidated by the
sevenfold increase of B19 infectious particles production
when CD36+ human primary erythroid cells were incubated
in hypoxic conditions (Table 1).
B19 promoter contains a putative HIF-1 binding site
Our data demonstrate that hypoxia induces an increase
of B19 expression, replication, and virus production. As cell
response to hypoxic stress is mainly mediated by hypoxia-
inducible factor-1 (HIF-1) (for a review, see Hopfl et al.,
2004), we explored if this transcription factor is involved in
the viral upregulation observed. We first looked for a
putative HIF-1 binding site (HBS) in the B19 genome.
Analysis of the complete P6 promoter sequence revealed
the presence of a single putative binding site (5V-
GACGTGCCA-3V) for HIF-1 294 bp upstream of the TATA
box (Momoeda et al., 1994). This hypothetical HBS shares
high similarity with the published mammalian HBS consen-
sus sequence (Camenisch et al., 2001), and is conserved in
various published B19 hairpin sequences (Fig. 2). The site is
located in the distal part of the hairpin that contains many
mismatches due to which only the ‘‘flop’’ conformation of
the single-stranded genome contains the GACGTGCCA
(Deiss et al., 1990; Zhi et al., 2004).
Hypoxic upregulation of parvovirus B19 expression might
involve HIF-1-dependent transcriptional activation
HIF-1 is a ubiquitously expressed heterodimeric tran-
scription factor consisting of a hypoxia-regulated a-subunit
and an oxygen-insensitive h-subunit (also known as aryl
hydrocarbon receptor nuclear translocator, ARNT). Under
hypoxic conditions, instantaneous stabilization of HIF-1aenables association with ARNT in the nucleus, and DNA-
binding to the HBS either in a sense or an antisense
orientation. This is followed by the recruitment of the
CBP/p300 transcriptional co-activators and upregulation of
hypoxia-dependent target genes, such as erythropoietin,
aldolase, and vascular endothelial growth factor (VEGF)
(Hofer et al., 2002). Therefore, the expression of both
Table 1
Increase of B19 infectious particles production in hypoxic conditions
Volume of supernatant (Al) Normoxia Hypoxia
500 12 89
50 0 7
5 0 0
B19-infected CD36+ cells were incubated under normoxic and hypoxic
conditions. After 48 h exposure, supernatants were collected. Five, fifty,
and five hundred microliters of these supernatants were used to infect fresh
CD36+ cells in normoxic conditions. Infected cells were then immunos-
tained with anti-VP2 antibody and counted, giving the titer of infectious
B19 particles present in the initial supernatants. The experiment was
repeated three times. Because the permissiveness of CD36+ cells depends
of the human donor, the number of infected cells varies considerably from
experiment to experiment; however, we found every times the same
activation factor between cells infected in normoxic and hypoxic
conditions using different lots of CD36+ cells. We show here a
representative experiment. Normoxia: supernatant collected from CD36+
cells infected in normoxia. Hypoxia: supernatant collected from CD36+
cells infected in hypoxia.
S. Pillet et al. / Virology 327 (2004) 1–7 3proteins constituting the HIF-1 heterodimer was verified in
primary erythroid cells exposed to low oxygen tension.
Fig. 3A shows that hypoxic exposure leads to stabilization
of HIF-1a in CD36+ human primary erythroid cells. As
shown previously, under hypoxia, the oxygen-insensitive
HIF-1h subunit (ARNT) tends to enter the nucleus as a
heterodimer with HIF-1a (Chilov et al., 1999). This pro-
vides an explanation for the increased ARNT levels ob-
served in the nuclear fraction under hypoxic conditions.Fig. 2. Left part of B19 genome contains a putative HBS. (A). Localization of the p
B19 genomes are converted during viral replication into double-stranded genome
orientation. The HBS exists only in B19 single-stranded genomes in the ‘‘flop’’ co
Nucleotide positions of the TATA box and the extremity of the left hairpin are show
et al. (1994). (B). Conservation of the putative B19 HBS with mammalian con
mammalian HBS consensus (core and flanking sequences) (Camenisch et al., 2001
the complete P6 promoter sequence described by Momoeda et al. (1994). The co
found in all published B19 left hairpin sequences [(3) Deiss et al., 1990; (2) Gal
Kakkola, Hedman, and Soderlund-Venermo, with permission; (1) Momoeda et alSubsequently, the HIF-1-binding properties to the putative
viral promoter HBS were analyzed by electrophoretic mobil-
ity shift assays. Incubation of a B19-derived oligonucleotide
with nuclear extracts isolated from CD36+ cells revealed the
presence of a HIF-1/DNA-binding complex mainly formed
with the hypoxic cell extracts (Fig. 3B). Competition experi-
ments using unlabeled wild-type and mutated oligonucleo-
tides as well as supershifts using specific anti-HIF-1a and
anti-HIF-1h antibodies demonstrated the specificity of this
HIF-1/DNA interaction (Fig. 3B). Finally, reporter gene
analysis was performed to show the functional responsive-
ness of the predicted B19 promoter HBS. SV40 promoter-
driven luciferase reporter gene constructs, containing either
wild-type or mutant B19-derived HBS, were transfected into
wild-type and HIF-1a-deficient CHO cell lines. Exposure to
hypoxia led to a weak but reproducible increase of luciferase
expression from the wild-type B19 and VEGF promoter HBS
in wild-type CHO cells, but not in the HIF-1a-deficient CHO
cell line (Fig. 3C). Similar results were found with desfer-
rioxamin, an iron chelator, known to functionally stabilize
HIF-1a (data not shown).Discussion
Our results clearly demonstrate that B19 erythrovirus
protein expression and replication in human primary ery-
throid progenitors are upregulated by reduced oxygen sup-utative HBS in the sequence of the left B19 hairpin. ‘‘Flop’’ single-stranded
s that contain the HBS 294 bp upstream of the TATA box in an antisense
nformation of the ‘‘bubble’’ of the hairpin (according to Deiss et al., 1990).
n according to the complete P6 promoter sequence described by Momoeda
sensus sequence. B19 sequences contain a motif strongly resembling the
). Nucleotide positions of the B19 hairpin sequences are shown according to
re sequence of cellular and viral HBS is shown in bold. This sequence was
linella G. and Venturolli S., 1999 Genbank access number: AF162273; (4)
., 1994; (5) Zhi et al., 2004].
Fig. 3. Evidence that hypoxic upregulation of B19 erythrovirus expression
involves HIF-1. (A) Immunoblot analysis of HIF-1a and ARNT (the
h subunit of HIF-1) expression in nuclear extracts prepared from
noninfected CD36+ cells grown under normoxic or hypoxic conditions
during 30 h. The signal obtained with an anti-RXR antibody was used as a
control for loading and transfer efficiency. (B) DNA-binding assays of
nuclear extracts prepared from noninfected CD36+ cells grown under
normoxic or hypoxic conditions during 30 h. Possible HIF-1 DNA-binding
activity was analyzed in nuclear extracts using a 32P-radiolabeled probe
containing the HBS of the B19 promoter (lanes 1 and 2). Competition
experiments were performed using a 50-fold excess of probe containing the
wild-type B19 HBS (ACGTG) (lane 3) or with a probe containing a
mutated HBS (TTTTG) (lane 4). Specific HIF-1 DNA binding was
confirmed by supershift analysis using two different anti-HIF-1a antibodies
(lanes 5 and 6) and an anti-ARNT antibody (lane 7). The cellular HBS can
also be recognized by the oxygen-insensitive transcription complex ATF-1/
CREB (Kvietikova et al., 1995). This complex can bind constitutively to the
putative HBS present in B19 P6 promoter, and supershift experiments were
performed to verify its specificity (data not shown). (C) Luciferase reporter
gene assays of transiently transfected wild-type (C4.5) or HIF-1a-deficient
(Ka13) CHO cells cultured under normoxic and hypoxic conditions for 48
h. An SV40 promoter-driven luciferase reporter gene construct contained
either the wild-type or the mutant B19 promoter-derived HBS. A cor-
responding luciferase expression plasmid, containing the VEGF promoter-
derived HBS, served as positive control. A cotransfected h-galactosidase
expression vector was used as an internal control for transfection efficiency
and to correct the luciferase expression. On the vertical axis, the ratio of
corrected luciferase expression is represented as obtained under hypoxic
versus normoxic conditions. Mean F standard error of the mean of three
independent transfections is shown.
S. Pillet et al. / Virology 327 (2004) 1–74ply (Fig. 1). Hypoxia leads to higher proportion of cells
expressing viral proteins (Fig. 1C). This could be due to a
higher proportion of infected cells, and also a higher level of
expression in each cells leading to its visualization in
immunofluorescence analysis. In our model, erythroid cells
are infected in normoxic conditions, meaning that virus-
receptor interaction and virus internalization occurred at
20% oxygen. This was done to avoid the possibility that
hypoxia could act on the attachment or internalization
phase. It has also been shown that the expression of the
cellular P antigen, the main B19 receptor, is not regulated by
hypoxia at the surface of KU812F cells (P. Caillet-Fauquet
et al., in press). However, we cannot completely exclude a
possible influence of hypoxia on the migration of viral
capsids through the cytoplasm and their entry into the
nucleus.
Oxygen tension has been previously reported as a factor
that may affect viral multiplication (Ebbesen and Zachar,
1998). The recently reported study on human herpesvirus
8 (HHV8) demonstrates that HIF-1, the main cellular
hypoxia-responsive transcription factor, is directly implicat-
ed in the activation of HHV8 transcription and replication in
chronically infected cells (Haque et al., 2003). As we
detected the presence of an HBS in the B19 promoter
(Fig. 2), it was studied whether HIF-1 could also be
implicated in the transcriptional activation of B19 expres-
sion leading to higher viral protein synthesis. Hypoxic
erythroid cells express high level of HIF-1a that can bind
the viral HBS found in the B19 promoter (Figs. 3A and B).
Nevertheless, the discrepancy between the high increase of
viral mRNA steady-state levels (Fig. 1A) and the quite low
induction levels of luciferase expression (Fig. 3C) was
surprising. To our opinion, this could be explained in the
following three ways. First, the intracellular environment is
different between the infection and the transfection models
(CD36 vs. CHO cells); however, as it is extremely difficult
to transfect primary erythroid cells (data not shown), re-
porter gene expression had to be studied in CHO cell lines.
Second, the P6 promoter may harbor additional binding
sites for other oxygen-sensitive factors as shown for the
endothelin-1 (ET-1) promoter (Camenisch et al., 2001;
Yamashita et al., 2001). Previous studies have shown that
the proximal part of the B19 promoter can adopt a confor-
mation that could favor the interaction between distantly
binding factors leading to optimal transcriptional activation
(Gareus et al., 1998). Additional experiments with a com-
plete B19 infectious clone should be helpful to understand
the involvement of HIF-1a and relatives in the transcrip-
tional activation of B19 expression under low oxygen
tension levels. Third, as described for several cellular genes,
hypoxia could also increase viral mRNA stability. However,
the extreme toxicity of the actinomycin D and cyclohexi-
mide treatments in the primary erythroid cells did not allow
us to study eventual changes in B19 mRNA half time.
In our model, hypoxia repeatedly reduced the number of
CD36+ erythroid cells after 24 and 48 h of incubation (data
S. Pillet et al. / Virology 327 (2004) 1–7 5not shown). Previous reports showed that oxygen supply
has an impact on cell maturation and differentiation. Partic-
ularly, low oxygen tension levels enhance BFU-E and CFU-
E in vitro (Cipolleschi et al., 1997; Koller et al., 1992)
maintaining erythroid progenitors in a high B19-sensitive
stage (Takahashi et al., 1990). Oxygen tension measure-
ments and mathematical models showed that bone marrow
contains low level and that proliferation of erythroid pro-
genitors occurs in hypoxic conditions (Chow et al., 2001;
Harrison et al., 2002; Ishikawa and Ito, 1988). As a
consequence, we can speculate that hypoxia, by maintaining
cells in undifferentiated stages, could possibly help B19
expression and replication, leading to high-grade viremia
especially in patients producing high numbers of erythroid
progenitor cells (Brown and Young, 1997). Similarly, the
high fetal sensitivity to B19 infection could be explained, in
addition to the high proportion of erythroid progenitors, by
the hypoxic development of fetal tissues (Adelman et al.,
1999; Iyer et al., 1998).
Taken together, our data show that the hypoxia enhances
significantly the expression and the replication of human B19
erythrovirus in vitro. The low oxygen tension levels mea-
sured in several tissues could contribute to B19 replication in
sensitive cells in vivo. The mechanisms implicated in this
oxygen-upregulated gene expression are probably complex
but should be explored in more detail to elucidate the sharp
erythroid tropism of B19 erythrovirus. Actually, few infec-
tion models are available for in vitro B19 replication, and the
production of infectious particles is very low. Transfection of
cells with the very recently obtained infectious clone (Zhi
et al., 2004) in hypoxic conditions should be very useful to
produce high reproducible viral titers, either wild type or
recombinant, and study in depth B19 biology.Materials and methods
Cell culture and infection
CD36+ primary erythroid cells were obtained as previ-
ously described (Freyssinier et al., 1999). Normoxic CD36+
cells were infected with 20% sucrose cushion-purified
infectious B19 erythrovirus particles at a multiplicity of
infection of 0.1 as described (Sol et al., 1999). Briefly, cells
were incubated with the viral suspension under normoxic
conditions at 4 jC during 1 h and subsequently transferred
to 37 jC for 2 h; cells were then carefully washed three
times with sterile PBS to eliminate the viral inoculum and
subsequently incubated either in normoxia or hypoxia. For
transfection studies, C4.5 and Ka13 cells were cultured as
described (Wood et al., 1998). CD36 and CHO cells were
grown at 37 jC in a conventional incubator at pO2 of 140
mm Hg (20% O2 v/v, normoxia) or in hermetic boxes
(Modular Incubator Chamber, Billups-Rothenberg Inc.) in
which an hypoxic atmosphere was introduced: 7 mm Hg
(1% O2 v/v, hypoxia).Protein analysis
Immunofluorescence and immunoblot analysis were car-
ried out as described using rabbit anti-NS1 and VP2-specific
polyclonal antibodies (Pallier et al., 1997). Nuclear extracts
were prepared as previously described (Sol et al., 1999).
HIF-1 was detected by immunoblot analysis using specific
antibodies against HIF-1a (Transduction Laboratories) and
ARNT (a kind gift from O. Bernard).
Infectious particles count
To determine viral titers, CD36+ cells were infected
under normoxia with various volumes of viral suspensions
provided from infected CD36+ cells grown either under
normoxic or hypoxic conditions. After 48 h of exposure to
normoxic condition, 2.105 CD36+ cells were immunos-
tained using an anti-VP2 specific monoclonal antibody
(Chemicon).
Southern and Northern analysis
Viral replicative forms were isolated by performing a
Hirt extraction from 107 infected CD36+ cells cultured
either in normoxia or hypoxia, and analyzed using a 32P-
radiolabeled B19 genomic sequence as a probe according to
Ozawa et al. (1986).
Total RNA was extracted at 4jC from 106 CD36+
infected cells cultured either in normoxia or hypoxia, and
analyzed as previously described (Pallier et al., 1997). 32P-
radiolabeled B19 (nucleotides 1813–2451, Shade et al.,
1986) and aldolase (a kind gift from O. Bernard) were used
as probes. In order to correct for loading and blotting
efficiency, B19 mRNA signals were normalized to the
signal obtained with a 28S cDNA probe (Ambion).
Radioactive signals were quantified by phosphorimaging
(Molecular Imager System GS-525, Biorad).
Electrophoretic mobility shift assays
DNA-binding assays were carried out as described (Chi-
lov et al., 1999; Forsythe et al., 1996). A double-stranded
oligonucleotide (5V-TGATCTTAGTGGCACGTCAACC-
CCA-3V) containing the HBS of the B19 promoter was used
as a probe. An oligonucleotide containing the mutated HBS
(5V-TGATCTTAGTGGCTTTTCAACCCCA-3V) was used
for competition experiments. Specific HIF-1 DNA binding
was confirmed by supershift analysis using two anti-HIF-1a
(from Novus Biologicals and NeoMarkers) and one anti-
ARNT antibodies (Santa Cruz Biotechnology).
Transfection and reporter gene assays
An oligonucleotide containing either the wild-type (5V-
GTCTTAGTGGCACGTCAACCCCAA-3V) or the mutant
(5V-GTCTTAGTGGCTTTTCAACCCCAA-3V) B19 pro-
S. Pillet et al. / Virology 327 (2004) 1–76moter-derived HBS was cloned in an antisense orientation
into a MluI–XhoI-opened pGL2-promoter vector (Prom-
ega). A corresponding luciferase expression plasmid, con-
taining the VEGF promoter-derived HBS (Forsythe et al.,
1996), served as positive control. Wild-type (C4.5) or HIF-
1a-deficient (Ka13) CHO cells were transiently transfected
with Lipofectin according to the manufacturer’s recommen-
dations (Invitrogen). After 48 h exposure to normoxia or
hypoxia, luciferase detection and correction of transfection
efficiency by h-galactosidase expression (Roche) were
carried out as described (Semenza et al., 1996). The reporter
gene transfection experiments were performed independent-
ly at least three times in duplicate.Acknowledgments
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